Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.

Yoshinaga OkugawaYuji ToiyamaKunitoshi ShigeyasuAkira YamamotoTsunehiko ShigemoriChengzeng YinTakashi IchikawaHiromi YasudaHiroyuki FujikawaShigeyuki YoshiyamaJunichiro HiroMasaki OhiToshimitsu ArakiMasato KusunokiAjay Goel

Published in: Journal of translational medicine (2018)

AZIN1 RNA editing levels may be an important prognostic biomarker in GC patients, and may serve as a key clinical decision-making tool for determining preoperative treatment strategies in GC patients.

Keyphrases

end stage renal disease
ejection fraction
crispr cas
newly diagnosed
chronic kidney disease
decision making
peritoneal dialysis
prognostic factors
transcription factor
patients undergoing
patient reported outcomes
high resolution
patient reported
gas chromatography